Qian, Luheng https://orcid.org/0009-0009-6347-491X
Shi, Runye
Yu, Xinyang https://orcid.org/0000-0001-8026-4839
Chen, Di https://orcid.org/0000-0001-5620-9020
Banaschewski, Tobias https://orcid.org/0000-0003-4595-1144
Bokde, Arun L. W. https://orcid.org/0000-0003-0114-4914
Flor, Herta https://orcid.org/0000-0003-4809-5398
Grigis, Antoine
Garavan, Hugh https://orcid.org/0000-0002-8939-1014
Gowland, Penny https://orcid.org/0000-0002-4900-4817
Heinz, Andreas https://orcid.org/0000-0001-5405-9065
Martinot, Jean-Luc https://orcid.org/0000-0002-0136-0388
Martinot, Marie-Laure Paillère
Artiges, Eric https://orcid.org/0000-0003-4461-7646
Nees, Frauke https://orcid.org/0000-0002-7796-8234
Papadopoulos Orfanos, Dimitri https://orcid.org/0000-0002-1242-8990
Poustka, Luise
Hohmann, Sarah https://orcid.org/0000-0002-5175-6698
Holz, Nathalie https://orcid.org/0000-0002-6225-9267
Smolka, Michael N. https://orcid.org/0000-0001-5398-5569
Vaidya, Nilakshi https://orcid.org/0000-0002-4600-7158
Walter, Henrik https://orcid.org/0000-0002-9403-6121
Whelan, Robert https://orcid.org/0000-0002-2790-7281
Schumann, Gunter https://orcid.org/0000-0001-9473-1047
Lin, Xiaolei https://orcid.org/0000-0003-2463-1272
Desrivières, Sylvane https://orcid.org/0000-0002-9120-7060
,
Article History
Received: 23 December 2024
Accepted: 4 May 2026
First Online: 5 June 2026
Competing interests
: T.B. served in an advisory or consultancy role for eye level, Infectopharm, Medice, Neurim Pharmaceuticals, Oberberg GmbH and Takeda. He received conference support or speakers fees from Janssen-Cilag, Medice and Takeda. He received royalties from Hogrefe, Kohlhammer, CIP Medien and Oxford University Press. L.P. served in an advisory or consultancy role for Roche and Viforpharm and received speakers fees from Shire. She received royalties from Hogrefe, Kohlhammer and Schattauer. The present work is unrelated to the above grants and relationships. The other authors declare no competing interests.